COMMISSION IMPLEMENTING REGULATION (EU) 2021/824 of 21 May 2021 amending Implementing Regulations (EU) No 540/2011 and (EU) No 820/2011 as regards the conditions of approval of the active substance terbuthylazine ANNEX I ‘ANNEX I ANNEX II
Changelog
0 versionsArticle-level history is being prepared
The official source publishes these consolidated versions; article-by-article changes will appear here as soon as they are processed.
No consolidated versions are recorded for this law.